Cardiovascular Outcomes With Tirzepatide Versus GLP-1 Receptor Agonists in Overweight or Obesity: A Systematic Review and Meta-Analysis.

Silva JPMRJ, Nogueira BV, Sartori DL, da Silva JRC, Sciota LBA, de Mendonça Bisneto OI, Gomes WF

DOI: 10.1111/dom.71051
Published: 2026 Sep
Container: Diabetes, obesity & metabolism
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/dom.71051,
  title = {Cardiovascular Outcomes With Tirzepatide Versus GLP-1 Receptor Agonists in Overweight or Obesity: A Systematic Review and Meta-Analysis.},
  author = {Silva JPMRJ and Nogueira BV and Sartori DL and da Silva JRC and Sciota LBA and de Mendonça Bisneto OI and Gomes WF},
  year = {2026},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.71051},
  url = {https://doi.org/10.1111/dom.71051}
}

RIS

TY  - JOUR
TI  - Cardiovascular Outcomes With Tirzepatide Versus GLP-1 Receptor Agonists in Overweight or Obesity: A Systematic Review and Meta-Analysis.
AU  - Silva JPMRJ
AU  - Nogueira BV
AU  - Sartori DL
AU  - da Silva JRC
AU  - Sciota LBA
AU  - de Mendonça Bisneto OI
AU  - Gomes WF
PY  - 2026
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.71051
UR  - https://doi.org/10.1111/dom.71051
ER  -

APA

JPMRJ, S., BV, N., DL, S., JRC, D. S., LBA, S., OI, D. M. B., & WF, G. (2026). Cardiovascular Outcomes With Tirzepatide Versus GLP-1 Receptor Agonists in Overweight or Obesity: A Systematic Review and Meta-Analysis.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.71051

Source records

pubmed · retrieved 2026-09-26T08:27:57.809Z